Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND AND OBJECTIVE: Mild cognitive impairment (MCI) is a transitional state between normal aging and Alzheimer's disease (AD), and accurately predicting the progression trend of MCI is critical to the early prevention and treatment of AD. Brain structural magnetic resonance imaging (sMRI), as one of the most important biomarkers for the diagnosis of AD, has been applied in various deep learn...
Dementia affects the patient's memory and leads to language impairment. Research has demonstrated that speech and language deterioration is often a clear indication of dementia and plays a crucial role in the recognition process. Even though earlier studies have used speech features to recognize subjects suffering from dementia, they are often used along with other linguistic features obtained fro...
Deep neural networks are increasingly used for neurological disease classification by MRI, but the networks' decisions are not easily interpretable by...
PURPOSE: We present a systematic literature review of dialogue agents for Artificial Intelligence (AI) and agent-based conversational systems dealing ...
Acute activation of innate immune response in the brain, or neuroinflammation, protects this vital organ from a range of external pathogens and promot...
Exploring individual brain atrophy patterns is of great value in precision medicine for Alzheimer's disease (AD) and mild cognitive impairment (MCI). ...
Deep neural networks have been successfully applied to generate predictive patterns from medical and diagnostic data. This paper presents an approach ...
Brain tissue of Magnetic Resonance Imaging is precisely segmented and quantified, which aids in the diagnosis of neurological diseases such as epileps...
Amyloidogenesis is a critical hallmark for many neurodegenerative diseases and drug screening; however, identifying intermediate states of protein agg...
Selection of differentially expressed genes (DEGs) is a vital process to discover the causes of diseases. It has been shown that modelling of genomics...
The study aims to implement a convolutional neural network framework that uses the 18F-FDG PET modality of brain imaging to detect multiple stages of ...
An objective biomarker to predict the outcome of isolated rapid eye movement sleep behavior disorder (iRBD) is crucial for the management. This study ...
Alzheimer's disease is a neurodegenerative condition that gradually impairs cognitive abilities. Recently, various neuroimaging modalities and machine...
OBJECTIVES: Pet robots are technology-based substitutes for live animals that have demonstrated psychosocial benefits for people living with dementia ...
Alzheimer's disease (AD), a neurodegenerative disorder characterized by progressive cognitive decline, is generally prevalent in elderly people with s...
We introduce NeuroConstruct, a novel end-to-end application for the segmentation, registration, and visualization of brain volumes imaged using wide-f...
The limited accessibility of medical specialists for Alzheimer's disease (AD) can make obtaining an accurate diagnosis in a timely manner challenging ...
With modern population growth and an increase in the average lifespan, more patients are becoming afflicted with neurodegenerative diseases such as de...
Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not per...
Early diagnosis of Alzheimer's disease plays a pivotal role in patient care and clinical trials. In this study, we have developed a new approach based...